Shifa Biomedical Corp. is an American company located in Malvern, PA. The firm operates as a drug discovery company which develops drugs for treatment of cardiovascular disease. It was founded in 2006.\nThe company says this about itself: Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. It is a privately held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease. Incorporated in 2006, Shifa has recognized expertise for the discovery of small molecule drugs, including pharmaceutical experience guided by biochemical, cell-based, and virtual screening. Shifa scientists exploit molecular biology, biochemistry, crystallography and medicinal, computational and combinatorial chemistry. Shifa is led by a highly-experienced team of scientists with extensive expertise in early-stage drug discovery.

Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The company is considered a pioneer in the field of cell signaling and the control of gene expression. The company is focused primarily of three main areas; inflammation, metabolic diseases and oncology. Tularik was founded by David Goeddel along with Steve McKnight and Robert Tjian in 1991. The company was acquired by Amgen for US$ 1.3 billion in 2004.

Zota Health Care Ltd. engages in the manufacture, sale and export of pharmaceutical products. It includes ayurvedic, nutraceutical, and over-the-counter (OTC) products. The company was founded in 1995 and is headquartered in Surat, India.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA.

Sami-Sabinsa Group Ltd. manufactures & markets nutraceuticals, herbal extracts, chemicals and active pharmaceutical ingredients. It also offers probiotics, enzymes, spice extracts, minerals and oils. The company was founded in 1991 by Muhammed Majeed and is headquartered in Bangalore, India.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

D. & D. Srl provides environmental hygiene and reclamation services. It offers solutions for disinfestation of insects and pests, bird repulsion, and phytosanitary treatments. The company is headquartered in Modena, Italy.

Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. Its products also include PRT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company's products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Portola Pharmaceuticals, Inc. was founded in 2003 and is based in South San Francisco, California.

Beijing Chongsheng Pharmaceutical Technology Co., Ltd., established on 2015-10-30, The scope of business includes the sale of food;Internet information service;medical service;Technical extension services;health management(Except for medical treatment activities subject to approval);software development;Medical Research and Experimental Development;Economic Information Consulting(no intermediary);investment management,asset Management,Investment;design,make,acting,Place an ad;Organize cultural and artistic exchange activities(without show);Sales of daily necessities,household appliances,medical instrumentsIkind.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city;)

Starfield Food & Science Technology is a domestic plant-based artificial meat brand with its own R&D and manufacturing facilities. It was established in September 2019 in Shenzhen. It is committed to providing people with safe, healthy, and environmentally friendly food produced under scientific guidance, as well as making unrelenting efforts to indirectly eliminate famine and create a sustainable ecological environment, with the long-term goal of creating artificial meat products with indistinguishable facial features.

AQUANOVA AG operates as a manufacturing business to business enterprise. It supplies liquid solutions for raw materials and active substances such as vitamins, fatty acids or phytoextracts). The firm markets its products under the brand NovaSOL. The company was founded by Dariush Behnam in 1995 and is headquartered in Darmstadt, Germany.

Otsuka Foods Co. Ltd., a subsidiary of Otsuka Holdings Co., Ltd., is a Japanese company located in Osaka. The firm manufactures and sells food products and beverages through online.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Luoyang Xianghe Peony Technology Co., Ltd., established on 2007-02-10, Business scope includes food,food additives,pillow(pad),Research and development of handicrafts,Production(Operate according to the validity period approved by the production license);Pre-packaged food,cooking oil(free of bulk oil),roasted seeds and nuts,food additives,silk scarf,cosmetic,crafts,Office Supplies,Wholesale of daily necessities,retail;peony cultivation,grafting,planting research,to develop,to promote,Sales,consultation service;Housing rental service.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.